Cardlytics (Cardlytics) Change In Payables And Accrued Expense

: $-7.3 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

Cardlytics's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was $3.3 Mil. It means Cardlytics's Accounts Payable & Accrued Expense increased by $3.3 Mil from Sep. 2023 to Dec. 2023 .

Cardlytics's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $-7.3 Mil. It means Cardlytics's Accounts Payable & Accrued Expense declined by $7.3 Mil from Dec. 2022 to Dec. 2023 .

Cardlytics Change In Payables And Accrued Expense Historical Data

The historical data trend for Cardlytics's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardlytics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

5.55

-1.22

0.36

-10.41

-7.25

Cardlytics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-4.71	-4.83	-8.17	2.45	3.29

Cardlytics Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.3 Mil.

Cardlytics Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Cardlytics's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardlytics (Cardlytics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Communication Services » Media - Diversified » Cardlytics Inc (NAS:CDLX) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

CYX:Germany

Address

675 Ponce de Leon Avenue NE, Suite 6000, Atlanta, GA, USA, 30308

Website

https://www.cardlytics.com

Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through three segments, Cardlytics Direct U.S. and U.K., and the Bridg platform. The Cardlytics Direct segment which generates the majority of revenue operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

Executives

Clifford Sosin	10 percent owner	8 WRIGHT STREET, 1ST FL, WESTPORT CT 06880
Karim Saad Temsamani	director, officer: Chief Executive Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Nicholas Hollmeyer Lynton	officer: Chief Legal & Privacy Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Alex Mishurov	director	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVE. NE, SUITE 6000, ATLANTA GA 30308
Scott A Hill	director	INTERCONTINENTALEXCHANGE, INC., 2100 RIVEREDGE PKWY. STE. 500, ATLANTA GA 30328
Alexis Desieno	officer: Chief Financial Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Andrew Christiansen	officer: Chief Financial Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Chris Suh	director	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVE. NE, STE 6000, ATLANTA GA 30308
Jessica Jensen	director	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Amit Gupta	officer: Chief Operating Officer	C/O CARDLYTICS, INC, 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
John V Balen	director
Scott D. Grimes	director, officer: Chief Executive Officer	CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Lynne Marie Laube	director, officer: Chief Operating Officer	C/O CARDLYTICS, INC., 675 PONCE DE LEON AVENUE NE, SUITE 6000, ATLANTA GA 30308
Kirk Somers	officer: Chief Legal & Privacy Officer
S Aimee Lapic	director	2101 WEBSTER ST #1650, OAKLAND CA 94612